Renaming low risk conditions labelled as cancer

Brooke Nickel, Ray Moynihan, Alexandra Barratt, Juan P. Brito, Kirsten McCaffery*

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

10 Citations (Scopus)
178 Downloads (Pure)

Abstract

[Extract] Removing the cancer label in low risk conditions that are unlikely to cause harm if left untreated may help reduce overdiagnosis and overtreatment, argue Brooke Nickel and colleagues

Evidence is mounting that disease labels affect people’s psychological responses and their decisions about management options.1 The use of more medicalised labels can increase both concern about illness and desire for more invasive treatment. For low risk lesions where there is evidence of overdiagnosis and previous calls to replace the term cancer, we consider the potential implications of removing the cancer label and how this may be achieved.
Original languageEnglish
Article numberk3322
Number of pages8
JournalBMJ (Online)
Volume362
DOIs
Publication statusPublished - 12 Aug 2018

Fingerprint Dive into the research topics of 'Renaming low risk conditions labelled as cancer'. Together they form a unique fingerprint.

  • Cite this

    Nickel, B., Moynihan, R., Barratt, A., Brito, J. P., & McCaffery, K. (2018). Renaming low risk conditions labelled as cancer. BMJ (Online), 362, [k3322]. https://doi.org/10.1136/bmj.k3322